BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 8755738)

  • 21. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases.
    Reif DW; McCreedy SA
    Arch Biochem Biophys; 1995 Jun; 320(1):170-6. PubMed ID: 7540822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiols and neuronal nitric oxide synthase: complex formation, competitive inhibition, and enzyme stabilization.
    Gorren AC; Schrammel A; Schmidt K; Mayer B
    Biochemistry; 1997 Apr; 36(14):4360-6. PubMed ID: 9100033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcellular Targeting of Nitric Oxide Synthases Mediated by Their N-Terminal Motifs.
    Costas-Insua C; Merino-Gracia J; Aicart-Ramos C; Rodríguez-Crespo I
    Adv Protein Chem Struct Biol; 2018; 111():165-195. PubMed ID: 29459031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Structure-function relationships of NO synthase: electron transfer reaction].
    Sagami I; Sato Y; Shimizu T
    Seikagaku; 2003 May; 75(5):351-8. PubMed ID: 12822432
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of nitric oxide synthase as a potential therapeutic target.
    Hobbs AJ; Higgs A; Moncada S
    Annu Rev Pharmacol Toxicol; 1999; 39():191-220. PubMed ID: 10331082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Problem of biological properties of natural imidazole compounds].
    Severin SE
    Usp Sovrem Biol; 1965; 59(2):165-86. PubMed ID: 5322739
    [No Abstract]   [Full Text] [Related]  

  • 27. Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazole.
    Chabin RM; McCauley E; Calaycay JR; Kelly TM; MacNaul KL; Wolfe GC; Hutchinson NI; Madhusudanaraju S; Schmidt JA; Kozarich JW; Wong KK
    Biochemistry; 1996 Jul; 35(29):9567-75. PubMed ID: 8755738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative nitric oxide-producing substrates for NO synthases.
    Mansuy D; Boucher JL
    Free Radic Biol Med; 2004 Oct; 37(8):1105-21. PubMed ID: 15451052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure and activity of NO synthase inhibitors specific to the L-arginine binding site.
    Proskuryakov SY; Konoplyannikov AG; Skvortsov VG; Mandrugin AA; Fedoseev VM
    Biochemistry (Mosc); 2005 Jan; 70(1):8-23. PubMed ID: 15701046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of isoform-selective inhibitors of nitric oxide synthase.
    Babu BR; Griffith OW
    Curr Opin Chem Biol; 1998 Aug; 2(4):491-500. PubMed ID: 9736922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronal nitric oxide synthase, a modular enzyme formed by convergent evolution: structure studies of a cysteine thiolate-liganded heme protein that hydroxylates L-arginine to produce NO. as a cellular signal.
    Masters BS; McMillan K; Sheta EA; Nishimura JS; Roman LJ; Martasek P
    FASEB J; 1996 Apr; 10(5):552-8. PubMed ID: 8621055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide synthase inhibitors: a review of patents from 2011 to the present.
    Yang Y; Yu T; Lian YJ; Ma R; Yang S; Cho JY
    Expert Opin Ther Pat; 2015 Jan; 25(1):49-68. PubMed ID: 25380586
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.